B Taródi

458 total citations
20 papers, 395 citations indexed

About

B Taródi is a scholar working on Genetics, Molecular Biology and Epidemiology. According to data from OpenAlex, B Taródi has authored 20 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 8 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in B Taródi's work include Virus-based gene therapy research (12 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers) and Parvovirus B19 Infection Studies (4 papers). B Taródi is often cited by papers focused on Virus-based gene therapy research (12 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers) and Parvovirus B19 Infection Studies (4 papers). B Taródi collaborates with scholars based in Hungary, United States and Tanzania. B Taródi's co-authors include G. Chinnadurai, T. Subramanian, Rozália Pusztai, I Béládi, Tejas Subramanian, Emõke Endreffy, A. Babinszki, Attila Pál, Miklós Tóth and Janice M. Boyd and has published in prestigious journals such as Gene, Virology and Journal of General Virology.

In The Last Decade

B Taródi

20 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Taródi Hungary 10 187 165 116 102 94 20 395
Karin Öhman Sweden 6 379 2.0× 353 2.1× 94 0.8× 92 0.9× 68 0.7× 6 473
L J Eron United States 12 174 0.9× 110 0.7× 105 0.9× 52 0.5× 78 0.8× 17 376
E.M. Atkinson United Kingdom 9 250 1.3× 248 1.5× 59 0.5× 49 0.5× 53 0.6× 17 438
Heshan Sam Zhou United States 12 244 1.3× 245 1.5× 62 0.5× 138 1.4× 59 0.6× 18 372
Hamida Qavi United States 13 94 0.5× 146 0.9× 363 3.1× 75 0.7× 29 0.3× 34 511
Tanner M. Tessier Canada 10 138 0.7× 149 0.9× 57 0.5× 95 0.9× 85 0.9× 14 316
Eugene F. Gold Israel 8 132 0.7× 99 0.6× 188 1.6× 38 0.4× 39 0.4× 16 359
B R Bloom United States 10 79 0.4× 65 0.4× 138 1.2× 53 0.5× 41 0.4× 17 401
Claes Wohlfart Sweden 7 214 1.1× 279 1.7× 41 0.4× 98 1.0× 85 0.9× 7 356
Meigong Zhong China 9 163 0.9× 59 0.4× 170 1.5× 34 0.3× 48 0.5× 11 381

Countries citing papers authored by B Taródi

Since Specialization
Citations

This map shows the geographic impact of B Taródi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Taródi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Taródi more than expected).

Fields of papers citing papers by B Taródi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Taródi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Taródi. The network helps show where B Taródi may publish in the future.

Co-authorship network of co-authors of B Taródi

This figure shows the co-authorship network connecting the top 25 collaborators of B Taródi. A scholar is included among the top collaborators of B Taródi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Taródi. B Taródi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pusztai, Rozália, et al.. (2006). Prevalence and Avidity of Human Herpesvirus-6 Specific IgG Antibodies in Pregnant Women in Hungary. Acta Microbiologica et Immunologica Hungarica. 53(1). 25–34. 3 indexed citations
2.
Taródi, B, et al.. (2001). Human cytomegalovirus gB genotype 1 is dominant in congenital infections in South Hungary. Journal of Medical Virology. 65(3). 537–542. 1 indexed citations
3.
Taródi, B, et al.. (2001). Human cytomegalovirus gB genotype 1 is dominant in congenital infections in South Hungary*. Journal of Medical Virology. 65(3). 537–542. 45 indexed citations
4.
Subramanian, T., B Taródi, & G. Chinnadurai. (1995). Functional Similarity Between Adenovirus E1B 19-kDa Protein and Proteins Encoded by Bcl-2 Proto-Oncogene and Epstein-Barr Virus BHRF1 Gene. Current topics in microbiology and immunology. 199 ( Pt 1). 153–161. 11 indexed citations
5.
Subramanian, T., B Taródi, & G. Chinnadurai. (1995). p53-independent apoptotic and necrotic cell deaths induced by adenovirus infection: suppression by E1B 19K and Bcl-2 proteins.. PubMed. 6(2). 131–7. 79 indexed citations
6.
Taródi, B, T. Subramanian, & G. Chinnadurai. (1994). Epstein-Barr Virus BHRF1 Protein Protects against Cell Death Induced by DNA-Damaging Agents and Heterologous Viral Infection. Virology. 201(2). 404–407. 114 indexed citations
7.
Subramanian, T., B Taródi, R. Govindarajan, et al.. (1993). Mutational analysis of the transforming and apoptosis suppression activities of the adenovirus E1 B 175R protein. Gene. 124(2). 173–181. 30 indexed citations
8.
Mándi, Yvette, et al.. (1993). The Inhibitory Effect of Interferon-Alpha on the Serotonin-Induced Impairment of Human NK Cell Activity in Whole Blood. Brain Behavior and Immunity. 7(2). 164–175. 11 indexed citations
9.
Taródi, B, Tejas Subramanian, & G. Chinnadurai. (1993). FUNCTIONAL SIMILARITY BETWEEN ADENOVIRUS E1B 19K GENE AND BCL2 ONCOGENE - MUTANT COMPLEMENTATION AND SUPPRESSION OF CELL-DEATH INDUCED BY DNA-DAMAGING AGENTS. International Journal of Oncology. 3(3). 467–72. 25 indexed citations
10.
Molnár, Joséph, B Taródi, Márta Gálfi, B. Matkovics, & Noboru Motohashi. (1992). In vitro antiproliferative effects of tricyclic psychopharmaceutical agents and synergism with some resistance modifiers.. PubMed. 12(1). 273–80. 5 indexed citations
11.
Mándi, Yvette, et al.. (1987). The role of interferon in the adenovirus-induced augmentation of granulocyte-mediated cytotoxicity in chicken. Immunobiology. 174(2). 210–220. 2 indexed citations
12.
Pusztai, Rozália, B Taródi, & I Béládi. (1986). Production and characterization of interferon induced in chicken leukocytes by concanavalin A.. PubMed. 30(2). 131–6. 19 indexed citations
13.
Tóth, Miklós, et al.. (1983). Different interferon-inducing ability of human adenovirus types in chick embryo cells.. PubMed. 27(4). 337–45. 10 indexed citations
14.
Taródi, B, Rozália Pusztai, & I Béládi. (1982). Structural Polypeptides of Type 12 Human Adenovirus. Journal of General Virology. 62(2). 379–383. 1 indexed citations
15.
Tóth, Miklós, B Taródi, & I Béládi. (1982). Preparative separation of intact incomplete and empty adenovirus type 2 particles.. PubMed. 26(4). 217–20. 11 indexed citations
16.
Taródi, B, G. Eric Blair, David Rekosh, & W. C. Russell. (1979). Characterization of Two Temperature-sensitive Mutants of Adenovirus Type 5. Journal of General Virology. 43(3). 531–540. 7 indexed citations
17.
Béládi, I, et al.. (1979). Interferon induction by adenoviruses. Postgraduate Medical Journal. 55(640). 128–134. 5 indexed citations
18.
Pusztai, Rozália, B Taródi, & I Béládi. (1978). Characterization of Adenovirus Type 12 Tumour Antigen Produced in Chick Fibroblasts. Journal of General Virology. 41(2). 433–436. 3 indexed citations
19.
Taródi, B, et al.. (1977). A Study of Events in Chick Cells Infected with Human Adenovirus Type 5 and their Relationship to the Induction of Interferon. Journal of General Virology. 36(3). 425–436. 9 indexed citations
20.
Taródi, B, Rozália Pusztai, & Klára Berencsi. (1975). Physico-chemical characteristics of interferons induced by human adenovirus in chick fibroblasts and leucocytes.. PubMed. 19(5). 393–400. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026